LLY Competitors & Alternatives

Compare Eli Lilly and Company with similar stocks in the same industry

Drug Manufacturers - General

LLY

Main Stock
$1443.50
Tradestie Score
39
Market Cap
$739.95B
P/E Ratio
46.3
Revenue Growth
0.4%
Analyst Upside
+1.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 5/10 Drug Discovery Biotech Drug Design
Competitive Moat: oligopoly
Core Technology Stack: ['GLP-1/GIP dual agonists', 'AI-augmented molecular design', 'Large-scale clinical trial platforms']
Major Customers 5
Retail pharmacies Wholesalers (McKesson, Cardinal Health) Hospitals and clinics Specialty pharmacies Government programs (Medicare/Medicaid)
Critical Suppliers 5
Contract manufacturing organizations (CMOs) API chemical suppliers Clinical research organizations (CROs) Biotech research partners Raw material providers
Direct Ecosystem Rivals 4

Top Competitors

18 stocks in Drug Manufacturers - General
Company Price Market Cap P/E Score Action
AVGO Broadcom Inc. Common Stock
$347.01
$1.57T 46.5 52 Compare
JNJ Johnson & Johnson
$285.75
$448.07B 43.0 53 Compare
ABBV ABBVIE INC.
$295.03
$431.71B 50.6 49 Compare
NVO Novo-Nordisk A/S
$41.63
$262.92B 10.4 45 Compare
AZN AstraZeneca PLC
$184.45
$261.56B 26.1 37 Compare
NVS Novartis AG
$160.50
$254.99B 30.6 36 Compare
ABT Abbott Laboratories
$108.52
$232.30B 40.0 49 Compare
MRK Merck & Co., Inc.
$147.76
$225.13B 148.4 53 Compare
AMGN Amgen Inc
$465.67
$160.70B 27.1 39 Compare
PFE Pfizer Inc.
$28.89
$154.70B 41.2 49 Compare

Data updated: Nov 15, 2026 | Industry: Drug Manufacturers - General (SIC 2834)

18 stocks in this industry